Dinoto Alessandro, Cacciaguerra Laura, Krecke Karl N, Chen John Jing-Wei, Wingerchuk Dean M, Weinshenker Brian G, Banks Samantha A, Lopez-Chiriboga Alfonso Sebastian, Valencia-Sanchez Cristina, Sechi Elia, Pittock Sean J, Flanagan Eoin P
From the Department of Neurology and Center for Multiple Sclerosis and Autoimmune Neurology (A.D., L.C., J.J.-W.C., B.G.W., S.A.B., S.J.P., E.P.F.), Mayo Clinic College of Medicine, Rochester, MN; Department of Neurosciences (A.D.), Biomedicine, and Movement Sciences, University of Verona, Italy; Department of Radiology (K.N.K.), Mayo Clinic; Department of Ophthalmology (J.J.-W.C.), Mayo Clinic College of Medicine, Rochester, MN; Department of Neurology (D.M.W., C.V.-S.), Mayo Clinic, Scottsdale, AZ; Department of Neurology (B.G.W.), University of Virginia, Charlottesville; Department of Neurology (A.S.L.-C.), Mayo Clinic College of Medicine, Jacksonville, FL; Neurology Unit (E.S.), University Hospital of Sassari, Italy; and Department of Laboratory Medicine and Pathology (S.J.P., E.P.F.), Mayo Clinic College of Medicine, Rochester, MN.
Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200344. doi: 10.1212/NXI.0000000000200344. Epub 2024 Dec 11.
To characterize the frequency and clinicoradiologic phenotype of cerebellar involvement in attacks of aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) which are incompletely captured in current diagnostic criteria.
Brain MRI scans from patients with AQP4+NMOSD in the Mayo Clinic database were reviewed, and those with cerebellar T2-hyperintense lesions ≤30 days from attack onset were included for clinical and radiologic characterization.
From 432 patients with AQP4+NMOSD, we identified 17 (4%) with cerebellar attacks. The median age at attack onset was 47 years (range, 7-74). Cerebellar symptoms and signs were noted in 16 (94%) of 17 and the remaining patient was intubated preventing a detailed cerebellar exam. The median Expanded Disability Status Scale score at nadir was 5 (range, 2-9.5). Sixteen (94%) had other regions involved during the attack, most frequently with brainstem or area postrema involvement. Cerebellar MRI T2-lesions (8 single; 11 contiguous with the brainstem; 6/15 [35%] enhancing) were located in cerebellar peduncles, 15 (inferior, 5; middle, 10; superior, 10), and cerebellar parenchyma, 8 (dentate, 4; medial, 2; lateral, 4). T2-lesions persisted in 9 (82%) of 11 beyond 6 months.
Cerebellar involvement during attacks of AQP4+NMOSD is rare but the associated neurologic deficits tend to be severe. Cerebellar peduncle or dentate nucleus T2-lesions are frequent MRI accompaniments. Clinical features and MRI lesion patterns of cerebellar involvement could be incorporated into future iterations of AQP4+NMOSD criteria.
描述水通道蛋白4-IgG阳性视神经脊髓炎谱系障碍(AQP4+NMOSD)发作时小脑受累的频率及临床放射学表型,目前的诊断标准未能完全涵盖这些情况。
回顾梅奥诊所数据库中AQP4+NMOSD患者的脑部MRI扫描结果,纳入发病30天内出现小脑T2高信号病变的患者进行临床和放射学特征分析。
在432例AQP4+NMOSD患者中,我们识别出17例(4%)有小脑发作。发作起始的中位年龄为47岁(范围7 - 74岁)。17例中有16例(94%)出现小脑症状和体征,其余患者因插管无法进行详细的小脑检查。病情最低点时扩展残疾状态量表评分的中位数为5分(范围2 - 9.5分)。16例(94%)在发作期间有其他部位受累,最常见的是脑干或最后区受累。小脑MRI T2病变(8个单发;11个与脑干相连;15个中有6个[35%]有强化)位于小脑脚,15个(下脚,5个;中脚,10个;上脚,10个),以及小脑实质,8个(齿状核,4个;内侧,2个;外侧,4个)。11例中有9例(82%)的T2病变在6个月后仍持续存在。
AQP4+NMOSD发作时小脑受累罕见,但相关神经功能缺损往往严重。小脑脚或齿状核T2病变是常见的MRI伴随表现。小脑受累的临床特征和MRI病变模式可纳入AQP4+NMOSD标准的未来修订版中。